Oncorus Stock Z Score
ONCRDelisted Stock | USD 0.04 0.01 14.71% |
Oncorus |
Oncorus Company Z Score Analysis
Oncorus' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Oncorus Z Score | -4.07 |
Most of Oncorus' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oncorus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Oncorus has a Z Score of -4.07. This is 160.3% lower than that of the Healthcare sector and 221.86% lower than that of the Biotechnology industry. The z score for all United States stocks is 146.67% higher than that of the company.
Oncorus Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oncorus' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oncorus could also be used in its relative valuation, which is a method of valuing Oncorus by comparing valuation metrics of similar companies.Oncorus is currently under evaluation in z score category among its peers.
Oncorus Fundamentals
Return On Equity | -1.25 | |||
Return On Asset | -0.32 | |||
Current Valuation | 25.71 M | |||
Shares Outstanding | 26.09 M | |||
Shares Owned By Insiders | 12.69 % | |||
Shares Owned By Institutions | 55.29 % | |||
Number Of Shares Shorted | 447.72 K | |||
Price To Book | 0.13 X | |||
EBITDA | (75.42 M) | |||
Net Income | (77.42 M) | |||
Cash And Equivalents | 100.24 M | |||
Cash Per Share | 3.86 X | |||
Total Debt | 70.65 M | |||
Debt To Equity | 0.72 % | |||
Current Ratio | 6.42 X | |||
Book Value Per Share | 1.19 X | |||
Cash Flow From Operations | (61.69 M) | |||
Short Ratio | 0.74 X | |||
Earnings Per Share | (5.49) X | |||
Target Price | 5.0 | |||
Number Of Employees | 64 | |||
Beta | 2.85 | |||
Market Capitalization | 3.15 M | |||
Total Asset | 145.59 M | |||
Retained Earnings | (272.01 M) | |||
Working Capital | 27.41 M | |||
Z Score | -4.07 | |||
Net Asset | 145.59 M |
About Oncorus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oncorus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncorus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncorus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Oncorus Stock
If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |